Rengo F, Trimarco B, Bonaduce D, Petretta M, Ferrara N, D'Ascia C, Saccá L
Acta Cardiol. 1979;34(4):259-67.
This study was undertaken in order to assess the K+ sparing ability of amiloride. Thirty patients with liver cirrhosis and ascites or congestive heart failure were divided into three groups and treated with amiloride (Group A), hydrochlorothiazide (Group B) and amiloride plus hydrochlorothiazide (Group C) for 15 days. In all groups there was an increased diuresis while only in group A and C there was a statistically significant rise of K+ serum levels and a slight increment of K+ urinary loss. Total body K+ evaluated by 42K increased in group A and C while decreased in group B. Our results seem to confirm that amiloride has a mild diuretic action with a powerful K+ sparing capacity; amiloride is also able to counterbalance and reverse hydrochlorthiazide induced K+ urinary loss.
本研究旨在评估阿米洛利的保钾能力。30例肝硬化腹水或充血性心力衰竭患者被分为三组,分别接受阿米洛利(A组)、氢氯噻嗪(B组)和阿米洛利加氢氯噻嗪(C组)治疗15天。所有组的尿量均增加,而只有A组和C组的血清钾水平有统计学意义的升高,尿钾排泄略有增加。通过42K评估的全身钾含量在A组和C组增加,而在B组减少。我们的结果似乎证实,阿米洛利具有轻度利尿作用且保钾能力强;阿米洛利还能够抵消并逆转氢氯噻嗪引起的尿钾丢失。